(19S,23S)-5β,19-Epoxy-19,23-dimethoxycucurbita-6,24-dien-3β-ol

Catalog No. :
ACLADO911
CAS No. :
1616120-83-2
Molecular Formula :
C32H52O4
Molecular Weight :
500.76

IUPAC Name:(3R,5S,8R,9R,10R,13S,14R,17R,18R)-18-methoxy-17-((2S,4R)-4-methoxy-6-methylhept-5-en-2-yl)-4,4,13,14-tetramethyl-1,3,4,8,10,11,12,13,14,15,16,17-dodecahydro-2H-5,9-(epoxymethano)cyclopenta[a]phenanthren-3-ol

(19S,23S)-5β,19-Epoxy-19,23-dimethoxycucurbita-6,24-dien-3β-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(19S,23S)-5β,19-Epoxy-19,23-dimethoxycucurbita-6,24-dien-3β-ol
IUPAC Name(3R,5S,8R,9R,10R,13S,14R,17R,18R)-18-methoxy-17-((2S,4R)-4-methoxy-6-methylhept-5-en-2-yl)-4,4,13,14-tetramethyl-1,3,4,8,10,11,12,13,14,15,16,17-dodecahydro-2H-5,9-(epoxymethano)cyclopenta[a]phenanthren-3-ol
Molecular FormulaC32H52O4
Molecular Weight500.76
SMILESCO[C@H]1[C@@]23[C@]4([H])[C@](C(C)([C@@H](CC4)O)C)(C=C[C@]2([H])[C@@]5([C@@](CC3)([C@@](CC5)([H])[C@@H](C)C[C@@H](OC)/C=C(C)\C)C)C)O1
InChI KeyCRZHMFVUXYIFSA-GFZCSUDHSA-N
Synonym(19S,23S)-5β,19-Epoxy-19,23-dimethoxycucurbita-6,24-dien-3β-ol;19-Norlanosta-6,24-diene-9-carboxaldehyde, 3,5-dihydroxy-23-methoxy-, cyclic 9,5-(methyl acetal), (αR,3α,8α,13α,14β,20S,23R)-
CAS No.1616120-83-2

Synthetic Route by SureRoute

1. ACLADO911 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLADO911 route product structure diagram
    ACLADO9111616120-83-2
Inquiry

2. ACLADO911 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLADO911 route product structure diagram
    ACLADO9111616120-83-2
Inquiry

Comments (0)